http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0205280-A3
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D521-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-08 |
| filingDate | 1986-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1988-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0205280-A3 |
| titleOfInvention | Tetrahydroimidazoquinazolinone cardiac stimulants |
| abstract | 1,2,3,5-Tetrahydroimidazo[2,1-b]quinazolin-2-(1H)-one ncardiac stimulants, and their pharmaceutically acceptable nsalts, of the formula:- n nor a pharmaceutically acceptable salt thereof, nwherein n"Het" is an optionally substituted 5- or 6-membered aronmatic heterocyclic group attached to the 6-, 7-, 8-, or 9-position nof said n1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-(1H)-one; nR, which is attached to the 6-, 7-, 8-, or 9-position, is nhydrogen, C₁-C₄ alkyl, C₁-C₄ alkoxy, hydroxy, hydroxymethyl, nhalo or CF₃; and nR¹, R², R³, R⁴ and R⁵ are each H or C₁-C₄ alkyl. |
| priorityDate | 1985-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 29.